Pubblicazioni

Overall survival and progression-free survival in patients with primary brain tumors after treatment: is the outcome of [18F] FDOPA PET a prognostic factor in these patients?

2019 - ANNALS OF NUCLEAR MEDICINE

Chiaravalloti, A.; Esposito, V.; Ursini, F.; Di Giorgio, E.; Zinzi, M.; Calabria, F.; Cimini, A.; Schillaci, O.

Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI

2015 - EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Cicone, F.; Filss, C. P.; Minniti, G.; ROSSI ESPAGNET, MARIA CAMILLA; Papa, A.; Scaringi, C.; Galldiks, N.; Bozzao, A.; Shah, N. J.; Scopinaro, F.; Langen, K. -J.